Gates Foundation Strategic Investment Fund Logo
Share this page:



Zyomyx is a private biotechnology company specializing in HIV CD4 diagnostics. Through investment from the foundation, Zyomyx is providing its proprietary technology to improve access to HIV point-of-care CD4 diagnostic tests in low-resource settings and at a lower cost.

Investment Exit Year: 2014

Case Study